Valuation: KPC Pharmaceuticals,Inc.

Market Cap 6.77B 1B 873M 806M 743M 1.4B 96.26B 1.43B 9.63B 3.79B 47.14B 3.75B 3.67B 162B P/E 2026 *
21.4x
P/E 2027 * 16.9x
Enterprise Value 6.77B 1B 873M 806M 743M 1.4B 96.26B 1.43B 9.63B 3.79B 47.14B 3.75B 3.67B 162B EV / Sales 2026 *
1x
EV / Sales 2027 * 0.94x
Free-Float
60.48%
Yield 2026 *
-
Yield 2027 * -
1 day-3.14%
1 week+8.09%
Current month+14.60%
1 month+10.63%
3 months-19.87%
6 months-30.62%
Current year-28.74%
1 week 8.29
Extreme 8.29
9.3
1 month 7.45
Extreme 7.45
9.3
Current year 7.45
Extreme 7.45
13.55
1 year 7.45
Extreme 7.45
15.08
3 years 7.45
Extreme 7.45
24.11
5 years 7.45
Extreme 7.45
26.09
10 years 5.95
Extreme 5.95
26.09
Manager TitleAgeSince
Director of Finance/CFO - 03/01/2023
President 55 28/09/2023
Corporate Officer/Principal 54 01/06/2007
Director TitleAgeSince
Chairman 59 19/01/2023
Director/Board Member 64 01/11/2009
Director/Board Member 55 18/10/2023
Change 5-day change 1-year change 3-year change Capi.($)
-3.14%+8.09%-38.06%-50.22% 1B
+0.85%-0.80%+52.79%+161.33% 1,051B
+1.23%-1.53%+54.58%+59.08% 609B
+0.04%+2.58%+34.47%+86.33% 450B
+0.78%-0.71%+29.28%+24.10% 330B
+1.41%+0.58%+35.44%+40.67% 284B
-0.27%-1.87%+22.34%+22.51% 263B
-1.76%+2.37%-20.43%-38.00% 223B
-1.42%+0.80%+24.27%+57.50% 198B
-1.48%+3.43%+24.08%+71.67% 167B
Average -0.38%+0.68%+21.88%+43.50% 357.61B
Weighted average by Cap. +0.37%+0.02%+37.49%+79.59%

Financials

2026 *2027 *
Net sales 6.8B 1B 876M 809M 745M 1.41B 96.58B 1.44B 9.67B 3.8B 47.3B 3.77B 3.68B 163B 7.23B 1.07B 933M 861M 793M 1.5B 103B 1.53B 10.29B 4.05B 50.33B 4.01B 3.92B 173B
Net income 317M 46.71M 40.82M 37.66M 34.72M 65.43M 4.5B 66.89M 450M 177M 2.2B 175M 172M 7.58B 400M 59.01M 51.57M 47.59M 43.86M 82.68M 5.68B 84.51M 569M 224M 2.78B 222M 217M 9.58B
Net Debt - -
Logo KPC Pharmaceuticals,Inc.
KPC Pharmaceuticals Inc is a China-based company primarily engaged in the research, development, manufacturing and sales of pharmaceuticals. The Company operates mainly through two segments. The Pharmaceutical segment focuses on the research and development and manufacturing of drugs for cardiovascular and cerebrovascular treatments, orthopedics, antimalarial drugs, gynecological drugs and digestive system drugs. The Pharmaceutical Wholesale segment is primarily engaged in the wholesale and retail of pharmaceuticals and medical devices. The Company conducts business in both domestic and overseas markets.
Employees
5,072
Date Price Change Volume
17/07/26 CN¥8.950 -3.14% 22,781,988
16/07/26 CN¥9.240 +4.52% 29,995,267
15/07/26 CN¥8.840 -0.79% 27,004,220
14/07/26 CN¥8.910 +1.48% 22,540,500
13/07/26 CN¥8.780 +6.04% 23,214,185
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
8.950CNY
Average target price
16.15CNY
Spread / Average Target
+80.45%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600422 Stock